Skip to main content

Advertisement

Log in

Use of Corynebacterium pseudodiphtheriticum for elimination of Staphylococcus aureus from the nasal cavity in volunteers exposed to abnormal microclimate and altered gaseous environment

  • Published:
Probiotics and Antimicrobial Proteins Aims and scope Submit manuscript

Abstract

Effectiveness of saline suspension of Corynebacterium pseudodiphtheriticum containing spray was assessed in a 30-days chamber experiment modeling the effects of hyperthermia and polluted air on humans. Spray was targeted at eliminating Staphylococcus aureus from the nasal cavity of human subjects. Three of four volunteers became S. aureus carriers in the course of the experiment, and one was a chronic carrier of methicillin-resistant S. aureus (MRSA). Spray application eradicated S. aureus in three subjects and reduced its presence in the MRSA carrier. Results of the study suggest that C. pseudodiphtheriticum can be used for control of S. aureus in the nasal environment. However, further investigations are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lindgren E, Ebi KL, Johannesson M (2010) Climate change and communicable diseases in the EU Member States. Handbook for national vulnerability, impact and adaptation assessments. European Centre for Diseases Prevention and Control

  2. Gasparrini A, Armstrong B (2011) The impact of heat waves on mortality. Epidemiology 22(1):68–73

    Article  Google Scholar 

  3. Anderson GB, Bell ML (2011) Heat waves in the United States: mortality risk during heat waves and effect modification by heat wave characteristics in 43 U.S. communities. Environ Health Perspect 119(2):210–218

    Article  Google Scholar 

  4. D’Ippoliti D, Michelozzi P, Marino C et al (2010) The impact of heat waves on mortality in 9 European cities: results from the EuroHEAT project. Environ Health 9:37

    Article  Google Scholar 

  5. Van De Griend P, Herwaldt LA, Alvis B, DeMartino M, Heilmann K, Doern G, Winokur P, Vonstein DD, Diekema D (2009) Community-associated methicillin-resistant Staphylococcus aureus, Iowa USA. Emerg Infect Dis 15(10):1582–1589

    Article  Google Scholar 

  6. Wiersma P, Tobin D’Angelo M, Daley WR, Tuttle J, Arnold KE, Ray SM, Ladson JL, Bulens SN, Drenzek CL (2009) Surveillance for severe community-associated methicillin-resistant Staphylococcus aureus infection. Epidemiol Infect 137(12):1674–1678

    Article  CAS  Google Scholar 

  7. Sdougkos G, Chini V, Papanastasiou DA, Christodoulou G, Stamatakis E, Vris A, Christodoulidi I, Protopapadakis G, Spiliopoulou I (2008) Community-associated Staphylococcus aureus infections and nasal carriage among children: molecular microbial data and clinical characteristics. Clin Microbiol Infect 14(11):995–1001

    Article  CAS  Google Scholar 

  8. Dailiana ZH, Rigopoulos N, Varitimidis SE, Poultsides L, Petinaki E, Malizos KN (2008) Clinical and epidemiological features of upper-extremity infections caused by Staphylococcus aureus carrying the PVL gene: a four-year study in Greece. Med Sci Monit 14(10):511–514

    Google Scholar 

  9. Taplin D, Zaias N, Rebell G (1965) Environmental influences on microbiology of the skin. Arch Environ Health 11:546–550

    Article  CAS  Google Scholar 

  10. Ilyin VK, Volozhin AI, Vikha GV (2005) Colonization resistance of organism in changed environments. Nauka, Moscow

    Google Scholar 

  11. Il’in VK, Kriukov AI, Volozhin AI, Istranov LP, Istranova EV, Kiriukhina NV, Starkova LV, Morozova IuA, Usanova NA (2008) Investigation of dysbiosis developing during “dry” immersion and methods of correction. Aviakosm Ekolog Med 42(5):70–74

    Google Scholar 

  12. Kriukov AI, Il’in VK, Volozhin AI, Istranov LP, Kiriukhina NV, Starkova LV, Morozova IuA, Usanova NA (2007) Experimental grounds for administration of probiotic drugs in conditions of hydroweightlessness. Vestn Otorinolaringol 4:30–33

    Google Scholar 

  13. Kriukov AI, Il’in VK, Istranov LP, Kiriukhina NV, Morozova IuA (2008) Effect of short-term application of a lactate-containing probiotic on the pharyngeal microbiota in healthy subjects. Vestn Otorinolaringol 5:51–53

    Google Scholar 

  14. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2003) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 344:11–16

    Article  Google Scholar 

  15. Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36:281–285

    Article  Google Scholar 

  16. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A et al (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703–705

    Article  Google Scholar 

  17. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR (2004) Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39:776–782

    Article  Google Scholar 

  18. Datta R, Huang SS (2008) Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47:176–181

    Article  Google Scholar 

  19. Wertheim HF, Melles DC, Vos MC et al (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5:751–762

    Article  Google Scholar 

  20. Bradley SF (2011) MRSA colonisation (eradicating colonisation in people without active/invasive infection). Clin Evid 17

  21. McConeghy KW, Mikolich DJ, LaPlante KL (2009) Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 29(3):263–280

    Article  CAS  Google Scholar 

  22. van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 8(4):CD006216. doi:10.1002/14651858.CD006216.pub2

  23. Zaloguev SN, Viktorov AN, Zarubina KV, Gorshkov VP (1979) Number of microorganisms released from the upper respiratory tract and the cutaneous integument of persons in a hermetically sealed location. Kosm Biol Aviakosm Med 13(5):61–65

    CAS  Google Scholar 

  24. Zaloguev SN, Viktorov AN, Startseva ND (1980) Sanitary-microbiologic and epidemiologic aspects of habitability. Probl Kosm Biol 42:80–140

    CAS  Google Scholar 

  25. Patel JB, Gorwitz RJ, Jernigan JA (2009) Mupirocin resistance. Clin Infect Dis 15(49(6)):935–941

    Article  Google Scholar 

  26. Caffrey AR, Quilliam BJ, LaPlante KL (2010) Risk factors associated with mupirocin resistance in methicillin-resistant Staphylococcus aureus. J Hosp Infect 76(3):206–210

    Article  CAS  Google Scholar 

  27. McNeil JC, Hulten KG, Kaplan SL, Mason EO (2011) Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother 55(5):2431–2433

    Article  CAS  Google Scholar 

  28. Bathoorn E, Hetem DJ, Alphenaar J, Kusters JG, Bonten MJ (2012) Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J Clin Microbiol 50(9):2947–2950

    Article  CAS  Google Scholar 

  29. Doebbeling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP (1994) Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 154(13):1505–1508

    Article  CAS  Google Scholar 

  30. Fernandez C, Gaspar C, Torrellas A, Vindel A, Saez-Nieto JA, Cruzet F, Aguilar L (1995) A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. J Antimicrob Chemother 35(3):399–408

    Article  CAS  Google Scholar 

  31. Coates T, Bax R, Coates A (2009) Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 64(1):9–15

    Article  CAS  Google Scholar 

  32. Light IJ, Walton RL, Sutherland JM, Shinefield HR, Brackvogel V (1967) Use of bacterial interference to control a staphylococcal nursery outbreak: deliberate colonization of all infants with the 502A strain of Staphylococcus aureus. Arch Pediatr Adolesc Med 113(3):291–300

    Article  CAS  Google Scholar 

  33. Keidel WN (1972) Staphylococcus 502a. Arch Pediatr Adolesc Med 123(6):613

    Article  CAS  Google Scholar 

  34. Houck PW, Nelson JD, Kay JL (1972) Fatal septicemia due to Staphylococcus aureus 502A: report of a case and review of the infectious complications of bacterial interference programs. Arch Pediatr Adolesc Med 123(1):45–48

    Article  CAS  Google Scholar 

  35. Park B, Iwase T, Liu GY (2011) Intranasal application of S. epidermidis prevents colonization by methicillin-resistant Staphylococcus aureus in mice. PLoS One 6(10):e25880. doi:10.1371/journal.pone.0025880

    Article  CAS  Google Scholar 

  36. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y (2010) Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 20(465 (7296)):346–349

    Article  Google Scholar 

  37. Linoli O, Marconi S, Garaffa M (1981) Quantitative bacterial ecology of normal nasal mucosa. Ann Sclavo 23(2):151–161

    CAS  Google Scholar 

  38. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F (2003) Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol 69(1):18–23

    Article  CAS  Google Scholar 

  39. Lemon KP, Klepac-Ceraj V, Schiffer HK, Brodie EL, Lynch SV, Kolter R (2010) Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio 1(3):e00129–10. doi:10.1128/mBio.00129-10

  40. Kwaszewska A, Szewczyk EM (2007) Production of antibacterial substances by resident corynebacteria isolated from human skin. Med Dosw Mikrobiol 59(3):251–257

    CAS  Google Scholar 

  41. Meitert E (1969) On bacteriocins of Corynebacterium diphtheriae. II. Study of the bacteriocins produced by C. diphtheriae, C. ulcerans, C. atypique, C. hoffmani and C. xerose. Arch Roum Pathol Exp Microbiol 28(4):1086–1097

    CAS  Google Scholar 

  42. Pátek M, Hochmannová J, Nesvera J, Stránský J (1986) Glutamicin CBII, a bacteriocin-like substance produced by Corynebacterium glutamicum. Antonie Van Leeuwenhoek 52(2):129–140

    Article  Google Scholar 

  43. Uehara Y, Nakama H, Agematsu K, Uchida M, Kawakami Y, Abdul Fattah AS, Maruchi N (2000) Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect 44(2):127–133

    Article  CAS  Google Scholar 

  44. Funke G, von Graevenitz A, Clarridge JE, Bernard KA (1997) Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10:125–159

    CAS  Google Scholar 

  45. Urquhart GED, Gould JC (1965) Simplified technique for counting the number of bacteria in urine and other fluids. J Clin Pathol 18(4):480–482

    Article  CAS  Google Scholar 

  46. Glück U, Gebbers JO (2003) Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77(2):517–520

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. V. Kiryukhina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiryukhina, N.V., Melnikov, V.G., Suvorov, A.V. et al. Use of Corynebacterium pseudodiphtheriticum for elimination of Staphylococcus aureus from the nasal cavity in volunteers exposed to abnormal microclimate and altered gaseous environment. Probiotics & Antimicro. Prot. 5, 233–238 (2013). https://doi.org/10.1007/s12602-013-9147-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12602-013-9147-x

Keywords

Navigation